NOVEN TO PRESENT AT BANC OF AMERICA SECURITIES SPECIALTY PHARMACEUTICALS CONFERENCE

Back

Miami, FL, July 25, 2005 -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that company representatives are scheduled to present at the Banc of America Securities Specialty Pharmaceuticals Conference in Southampton, New York, on Thursday, July 28, 2005 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be accessible to the public at www.noven.com and a rebroadcast will be available thereafter at the same site.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are sold in over 30 countries, and a range of new patches are being investigated and developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Back

Copyright ©  2005 Noven Pharmaceuticals, Inc. All rights reserved.